Hyperspectral and Multi-Modal Retinal Imaging for Assessment of Retinal Laser Damage

Award Information
Agency: Department of Defense
Branch: Air Force
Contract: FA8650-09-M-6995
Agency Tracking Number: F083-029-0181
Amount: $99,919.00
Phase: Phase I
Program: SBIR
Awards Year: 2009
Solicitation Year: 2008
Solicitation Topic Code: AF083-029
Solicitation Number: 2008.3
Small Business Information
Lickenbrock Technologies LLC
4041 Forest Park Ave., St. Louis, MO, 63108
DUNS: 176142693
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Timothy Holmes
 Chief Executive Officer
 (314) 615-6921
 holmes@lickenbrock.com
Business Contact
 Maria Holmes
Title: Chief Financial Officer
Phone: (314) 615-6922
Email: maria@lickenbrock.com
Research Institution
N/A
Abstract
The Phase I objective is a conceptual design of a hyperspectral/multimodal fundus camera for assessing laser damage.  The premise to be ultimately proven in this project is that damage to the fundus, from laser irradiation, may be characterized and detected by reflectance spectra, and by measuring function such as flow and perfusion.  The system will incorporate an existing fundus camera model (e.g., Topcon), custom optical components for hyperspectral/multimodal imaging and a computer interface for controlling the custom components.  Software will include specialized acquisition for hyperspectral imaging, automated alignment to compensate eye motion, compensation for illumination flicker, correction of nonuniform component spectra, and compensation of other imperfections, algorithms that highlight lesions, deconvolution for improving spatial and spectral resolving power, and algorithms for detecting flow and perfusion changes.  In Phase II, the prototype instrument will be built and tested with NHPs and/or humans in collaboration with Brooks AFB.  Tests with NHPs in detecting and characterizing laser-induced damage will be carried out.  In Phase III the commercial-ready models will be produced, first, for military applications, and secondly for private sector clinical applications.  Private sector applications include AMD, diabetic retinopathy, glaucoma and related conditions. BENEFIT: The most immediate military benefit will be the capability of diagnosing or comfirming laser damage to retinas/fundi.  Commercial applications are in clinical diagnosis and treatment of AMD, diabetic retinopathy and glaucoma, among others.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government